stocktools
Offerings // Can-Fite BioPharma Ltd.

CANF offering history

Every offering-related filing in Can-Fite BioPharma Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 866 filings back to Dec 1, 2011.

Last executed offering
Jul 29, 2025
424B4 — priced deal (shares or notes)
Last registration (announced)
Sep 25, 2026
F-3/A — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
4
S-1/S-3/F-series registrations
DateFilingWhat it means
Oct 9, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 9, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 9, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 25, 2026F-3/A →REGISTEREDF-3/A registration — capacity to sell shares, not a sale yet
Sep 25, 2026F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Sep 11, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 11, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 28, 2026F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Apr 3, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 3, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 31, 2026F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Mar 31, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 31, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 5, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 21, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 11, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 11, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 29, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 28, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 25, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jul 23, 2025F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
May 9, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 17, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 15, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 6, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 6, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 5, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 30, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 30, 2024F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Jun 28, 2024424B7 →UPDATEResale prospectus — existing holders registering to sell
Apr 9, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 5, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 28, 2023F-3/A →REGISTEREDF-3/A registration — capacity to sell shares, not a sale yet
Dec 12, 2023F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Nov 22, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 12, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 8, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 1, 2023F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Apr 24, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 10, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
CANF offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full CANF workspace →
CANF offering FAQ

When did CANF last execute an offering?

Per SEC filings, Can-Fite BioPharma Ltd.'s most recent priced offering document is a 424B4 filed 2025-07-29. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did CANF last announce or register an offering?

The most recent registration is a F-3/A filed 2026-09-25. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.